Literature DB >> 1900230

Activin-binding protein is present in pituitary.

K Kogawa1, T Nakamura, K Sugino, K Takio, K Titani, H Sugino.   

Abstract

A binding protein for activin was purified from bovine pituitary by affinity chromatography on dextran sulfate-Sepharose CL-4B and activin-Affi-Gel 10. A 52,700-fold purification over the starting crude homogenate was achieved. The purified preparation showed two bands of 36 and 33 kilodalton in sodium dodecyl sulfate-polyacrylamide gel electrophoresis under nonreducing conditions. The ability of each form of the protein to specifically bind activin was determined by ligand blot analysis and binding competition study. Each protein was found to have the same NH2-terminus and its sequence was identical to that of follistatin, which is a specific inhibitor of identical to that of follistatin, which is a specific inhibitor of FSH release. Moreover, the binding protein was shown to inhibit the spontaneous FSH release from cultured pituitary cells as does follistatin. These properties are the same as activin-binding protein that we have obtained from rat ovary. These results support a conclusion that activin-binding protein/follistatin exists also in the pituitary. Activin-binding protein has an ability to inhibit the activin-induced augmentation of FSH release from cultured pituitary cells as does inhibin. However, the inhibitory pattern by the binding protein was quite distinct from that of inhibin, suggesting that there may be different mechanism(s) for their antagonistic actions. Stoichiometric inhibition as shown by gel filtration analysis indicates that activin-binding protein binds activin to form an inactive equimolar complex having neither stimulatory nor inhibitory activity for FSH secretion by the pituitary. These findings suggest that activin is actually involved in FSH secretion in the pituitary and that the activin action in the pituitary is regulated by activin-binding protein/follistatin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900230     DOI: 10.1210/endo-128-3-1434

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Activin regulates luteinizing hormone beta-subunit gene expression through Smad-binding and homeobox elements.

Authors:  Djurdjica Coss; Varykina G Thackray; Chu-Xia Deng; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2005-06-16

Review 2.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

3.  Tissue-specific expression of inhibin/activin subunit and follistatin mRNAs in mid- to late-gestational age human fetal testis and epididymis.

Authors:  V J Roberts
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

4.  The Local Control of the Pituitary by Activin Signaling and Modulation.

Authors:  Louise M Bilezikjian; Wylie W Vale
Journal:  Open Neuroendocrinol J       Date:  2011-01-01

5.  Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila.

Authors:  L A Raftery; V Twombly; K Wharton; W M Gelbart
Journal:  Genetics       Date:  1995-01       Impact factor: 4.562

6.  Evidence for the participation of endogenous activin A/erythroid differentiation factor in the regulation of erythropoiesis.

Authors:  M Shiozaki; R Sakai; M Tabuchi; T Nakamura; K Sugino; H Sugino; Y Eto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

7.  Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto.

Authors:  Paul W Harms; Chenbei Chang
Journal:  Genes Dev       Date:  2003-10-16       Impact factor: 11.361

8.  Expression and localization of inhibin/activin and activin receptors in GH3 cells, a rat pituitary adenocarcinoma cell line.

Authors:  C Ying; Z Zhang; G Huang; S Q Li; S Y Ying
Journal:  J Endocrinol Invest       Date:  1996-01       Impact factor: 4.256

9.  Developmental changes in pituitary adenylate cyclase activating polypeptide expression during the perinatal period: possible role in fetal gonadotroph regulation.

Authors:  Joseph P Moore; Betty C Villafuerte; Christian A Unick; Stephen J Winters
Journal:  Endocrinology       Date:  2009-07-02       Impact factor: 4.736

10.  FoxL2 and Smad3 coordinately regulate follistatin gene transcription.

Authors:  Amy L Blount; Karsten Schmidt; Nicholas J Justice; Wylie W Vale; Wolfgang H Fischer; Louise M Bilezikjian
Journal:  J Biol Chem       Date:  2008-12-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.